Expertise in
1
conditions

Kefeng Q. Ding

No. 88 Jiefang Road, 31009, 
Hangzhou, CN 
Expertise in
1
conditions
No. 88 Jiefang Road, 31009, 
Hangzhou, CN 

Overview

Kefeng Ding practices practicing medicine in Hangzhou, China.

Ding is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Colorectal Cancer, Fecal Impaction, Liver Cancer, Colonoscopy, and Endoscopy.

They are actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 2 clinical trials.

Locations

No. 88 Jiefang Road, 31009, Hangzhou, China
Other Locations
No. 88, Jiefang Road, Hangzhou, China
Jiefang Road 88, Hangzhou, 310009, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Open-label, Parallel Controlled, Multi-center Phase III Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
A Randomized, Open-label, Parallel Controlled, Multi-center Phase III Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2026
Intervention Type: Drug
Study Phase: Phase 3
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial
Enrollment Status: Unknown
Publish Date: February 02, 2024
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 1 Less Clinical Trial

148 Total Publications

Dynamic regulation of lysine and arginine metabolism promotes immune evasion by limiting T cell function in cancer.
Dynamic regulation of lysine and arginine metabolism promotes immune evasion by limiting T cell function in cancer.
Journal: Science immunology
Published: July 24, 2026

Frequently Asked Questions about Kefeng Q. Ding

Is Kefeng Q. Ding a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Kefeng Q. Ding is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kefeng Q. Ding participate in research or clinical trials?

Yes. Kefeng Q. Ding has published 148 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Kefeng Q. Ding's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ding's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile